Long-term cross-sex hormone treatment is safe in transsexual subjects

Asian Journal of Andrology

Volumn 14, Issue 6, 2012, Pages 813-814

  Meriggiola, Maria Cristina ^a   Berra, Marta ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ETHINYLESTRADIOL; ILLICIT DRUG; TESTOSTERONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DRUG SAFETY; EVIDENCE BASED MEDICINE; FEMALE TO MALE TRANSSEXUAL; FOLLOW UP; GENDER DYSPHORIA; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HORMONAL THERAPY; HUMAN; MALE TO FEMALE TRANSSEXUAL; QUALITY OF LIFE; SEX REASSIGNMENT; SMOKING; SUICIDE; SURGERY; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 84869055518     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2012.89     Document Type: Article

References (19)

1. Asscheman H, Giltay EJ,Megens JA, de Ronde WP, van Trotsenburg MA et al. A longterm follow-up study of mortality in transsexuals receiving treatment with crosssex hormones. Eur J Endocrinol 2011; 164: 635-42.
2. Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, Gooren LJ, Meyer WJ 3rd et al. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2009; 94: 3132-54.
3. Gooren LJ, Giltay EJ, Bunck MC. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab 2008; 93: 19-25.
4. Asscheman H, Gooren LJ, Eklund PL. Mortality and morbidity in transsexual patients with cross-gender hormone treatment. Metabolism 1989; 38: 869-73. (Pubitemid 19229965)
5. Van Kesteren PJ, Asscheman H, Megens JA, Gooren LJ. Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol 1997; 47: 337-42. (Pubitemid 27395966)
6. Ott J, Kaufmann U, Bentz EK, Huber, JC, Tempfer CB. Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy. Dertil Steril 2010; 93: 1267-72.
7. Toorians AW, Thomassen MC, Zweegman S, Magdeleyns EJ, Tans G et al. Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. J Clin Endocrinol Metab 2003; 88: 5723-9. (Pubitemid 38033041)
8. Elamin MB, Garcia MZ, Murad MH, Erwin PJ, Montori VM. Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta-analyses. Clin Endocrinol 2010; 72: 1-10.
9. Lidegaard O, Nielsen LH, Skovlund CW, Skjeldestad FE, Lokkegaard E. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.BMJ 2011; 343: d6423.
10. Canonico, M, Plu-Bureau, G, Lowe, GD, Scarabin, PY. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.BMJ 2008; 336: 1227-31. (Pubitemid 351809317)
11. Rosendaal FR. Risk factors for venous thrombotic disease. Thromb Haemost 1999; 82: 610-9.
12. Olie V, Canonico M, Scarabin PY. Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women. Curr Opin Hematol 2010; 17: 457-63.
13. Gooren LJ. Clinical practice. Care of transsexual persons. N Engl J Med 2011; 364: 1251-7.
14. Traish AM, Gooren LJ. Safety of physiological testosterone therapy in women: lessons from female-tomale transsexuals (FMT) treated with pharmacological testosterone therapy. J SexMed 2010; 7: 3758-64.
15. Gooren LJ, Giltay EJ. Review of studies of androgen treatment of female-to-male transsexuals: effects and risks of administration of androgens to females. J Sex Med 2008; 5: 765-76. (Pubitemid 351472186)
16. Berra M, Armillotta F, D'Emidio L, Costantino A, Martorana G et al. Testosterone decreases adiponectin levels in female to male transsexuals. Asian J Androl 2006; 8: 725-9. (Pubitemid 44869622)
17. Davis SR. Cardiovascular and cancer safety of testosterone in women. Curr Opin Endocrinol Diabetes Obes 2011; 18: 198-203.
18. Motmans J, Meier P, Ponnet K, T'Sjoen G. Female and male transgender quality of life: socioeconomic and medical differences. J Sex Med 2012; 9: 743-50.
19. Salvador J, Massuda R, Andreazza T, Koff WJ, Silveira E et al. Minimum 2-year follow up of sex reassignment surgery in Brazilian male-to-female transsexuals. Psychiatry Clin Neurosci 2012; 66: 371-2.